ELIZABETH BYERS: Open Payments
NPI 1083123541 · LATROBE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 16 payments from 13 companies in 2025. Trend: 2023 $606 · 2024 $541 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $115 |
| Boston Scientific Corporation | 2 | $100 |
| Phathom Pharmaceuticals, Inc. | 2 | $80 |
| Verona Pharma, Inc. | 1 | $62 |
| ABBVIE INC. | 2 | $47 |
| Novo Nordisk Inc | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Inari Medical, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: MOUNJARO, WATCHMAN FLX, VOQUEZNA, Ohtuvayre, REXULTI, FLOWTRIEVER CATHETER, S, QULIPTA, LEQVIO.
Industry payments across PA — which companies pay providers there.
